From November 17 to 20, 2025, LaserBlood took part in the MEDICA 2025 in Düsseldorf, Germany — one of the world’s largest and most influential trade fairs for medical technology, diagnostics, and healthcare innovation.
At this year’s edition, our team presented the latest developments in LaserBlood’s approach to early pancreatic cancer detection, demonstrating ongoing enhancements in fluorescence lifetime analysis and diagnostic integration platforms. With a wide spectrum of exhibitors and thousands of international visitors converging on MEDICA’s extensive forums and conference stages, this event offered a valuable arena to engage with clinicians, researchers, technology partners, and industry decision-makers.
Participating in MEDICA 2025 allowed us not only to showcase our evolving technology within the global medical community but also to gather insights into broader trends in medical diagnostics and healthcare delivery. The discussions and connections made during these four days contributed to shaping our priorities for the coming year and strengthened our network of collaborators as LaserBlood moves toward clinical validation and real-world impact.